-
2024-514785-39-00
4
2021-09-24
Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) in adults
-
2024-515310-40-01
4
2021-08-04
Patients with a confirmed diagnosis of ovarian small cell carcinoma.
-
2024-516181-11-00
4
2021-06-10
RELAPSE/REFRACTORY B-CELL LYMPHOMA.
-
2024-510653-10-00
5
2021-06-04
Advanced or metastatic soft tissue sarcoma (STS) in patients ≥65 years
-
2023-505924-71-00
4
2021-05-12
Adult patients with metastatic and/or unresectable Non-Small Cell Lung
-
2023-505483-11-00
6
2021-05-02
Brain abscess
-
2023-507202-14-00
7
2021-04-29
Upper limb spasticity after stroke or traumatic brain injury
-
2024-518721-15-00
5
2021-04-13
Apathy
-
2023-509492-16-00
4
2021-03-30
Adult participants with metastatic (advanced) solid tumors.
-
2024-514025-30-00
4
2021-03-25
Ocular conservative treatment for retinoblastoma
-
2024-512671-12-00
10
2021-03-05
Unresectable head and neck squamous cell carcinoma, metastatic head an
-
2024-512229-10-00
4
2021-02-04
Takayasu arteritis
-
2024-516461-36-00
5
2021-01-27
Pregnancy associated hypertension, Pre-Eclampsia, Fetal growth restric
-
2024-516649-38-00
5
2020-12-01
Recurrent ovarian, fallopian tube or primary peritoneal cancer
-
2024-510783-23-00
7
2020-10-29
Fallopian Tube Cancer
-
2024-514349-13-00
5
2020-10-11
Excision-autograft surgery in burn patient
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2024-515844-22-00
4
2020-09-10
urethral posterior valve
-
2023-507885-21-00
4
2020-08-18
Chronic Inflammatory Demyelinating Polyneuropathy
-
2024-513248-27-00
5
2020-07-20
Patients, men or women over 18 old, with inoperable vertebral bone met
-
2022-501050-11-01
10
2020-07-13
Acute Lymphoblastic Leukaemia
-
2024-515276-12-00
5
2020-07-01
Postpartum Hemorrhage
-
2023-510567-35-00
4
2020-06-10
Advanced / metastatic cancers
-
2024-511620-13-00
4
2020-06-05
Patient presenting with:
- ectopic ossification secondary to iPPSD2 or